{{Rsnum
|rsid=12990906
|Gene=CASP8
|Chromosome=2
|position=201249901
|Orientation=plus
|GMAF=0.4247
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=CASP8
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 32.3 | 41.5 | 26.2
| HCB | 18.6 | 60.5 | 20.9
| JPT | 14.0 | 44.2 | 41.9
| YRI | 0.0 | 0.0 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 18.6 | 60.5 | 20.9
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}
{{PMID Auto
|PMID=20363033
|Title=Genetic association of CASP8 polymorphisms with primary progressive multiple sclerosis
}}{{PMID Auto
|PMID=22843554
|Title=Association between CASP8 and CASP10 polymorphisms and toxicity outcomes with platinum-based chemotherapy in Chinese patients with non-small cell lung cancer.
|OA=1
}}